Vitamins and Coenzymes Practice Questions

Q: Which drugs form complexes with pyridoxal?

Both Isoniazid and Penicillamine. **Explanation:** The correct answer is **Both Isoniazid and Penicillamine (Option D)**. This question tests the knowledge of drug-nutrient interactions involving **Vitamin B6 (Pyridoxine)**. **1. Why Isoniazid and Penicillamine are correct:** Both drugs contain functional groups that chemically react with the aldehyde group of **Pyridoxal Phosphate (PLP)**, the active form of Vitamin B6. * **Isoniazid (INH):** This anti-tubercular drug reacts with pyridoxal to form **pyridoxal-hydrazone complexes**. This not only inactivates the vitamin but also inhibits the enzyme *pyridoxal kinase*, preventing the formation of PLP. * **Penicillamine:** Used in Wilson’s disease and rheumatoid arthritis, it reacts with PLP to form a stable **thiazolidine derivative**, effectively depleting the body's functional B6 pool. **2. Why Rifampicin is incorrect:** Rifampicin is an enzyme inducer (Cytochrome P450) and is associated with hepatotoxicity and orange-colored secretions, but it does not chemically complex with or interfere with the metabolism of Pyridoxal. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **Sideroblastic Anemia:** B6 deficiency leads to impaired heme synthesis (as PLP is a cofactor for ALA synthase), resulting in microcytic hypochromic anemia with ringed sideroblasts. * **Peripheral Neuropathy:** The most common clinical manifestation of INH-induced B6 deficiency. It is standard practice to co-administer **10–50 mg/day of Pyridoxine** with Isoniazid. * **GABA Synthesis:** PLP is a cofactor for *Glutamate Decarboxylase*. Deficiency reduces GABA levels, which can lead to **seizures** (especially in acute INH toxicity). * **Other B6 Antagonists:** Hydralazine (antihypertensive) and Cycloserine (second-line ATT) also act as B6 antagonists.

Q: An individual with megaloblastic anemia is found to have a significant folate deficiency. Erythropoiesis is hampered in this patient due to his inability to perform which type of enzymatic reaction?

Methylation. **Explanation:** The correct answer is **Methylation**. Folate (Vitamin B9) in its active form, **Tetrahydrofolate (THF)**, serves as a carrier of one-carbon units (methyl, methylene, methenyl, formyl, and formimino groups). In the context of erythropoiesis, folate is essential for the synthesis of **dTMP (deoxythymidine monophosphate)** from dUMP. This reaction, catalyzed by *thymidylate synthase*, requires the transfer of a methyl group from N5,N10-methylene THF. A deficiency in folate leads to impaired DNA synthesis, causing "nuclear-cytoplasmic asynchrony" where the nucleus matures slower than the cytoplasm, resulting in **megaloblastic anemia**. Additionally, the conversion of homocysteine to methionine requires the transfer of a methyl group from N5-methyl THF (the "methyl trap" link with Vitamin B12). **Why other options are incorrect:** * **Acyl transfer:** This is primarily the function of **Coenzyme A (Vitamin B5)** and Thiamine (B1). * **Carboxylation:** This involves the addition of $CO_2$, a process dependent on **Biotin (Vitamin B7)** (e.g., Pyruvate carboxylase). * **Decarboxylation:** This is typically mediated by **Pyridoxal Phosphate (PLP/Vitamin B6)** or **Thiamine Pyrophosphate (TPP/Vitamin B1)**. **High-Yield Clinical Pearls for NEET-PG:** * **FIGLU Excretion Test:** Histidine loading leads to increased Formiminoglutamate (FIGLU) in urine in folate deficiency. * **The Methyl Trap Hypothesis:** Vitamin B12 deficiency leads to a functional folate deficiency because folate remains trapped as N5-methyl THF, unable to be recycled. * **Drug Link:** **Methotrexate** inhibits *Dihydrofolate Reductase (DHFR)*, preventing the regeneration of THF, thus mimicking folate deficiency.

Q: What is the biochemical role of vitamin K in the post-translational modification of clotting factors?

Carboxylation. **Biochemical Explanation:** Vitamin K serves as an essential cofactor for the enzyme **gamma-glutamyl carboxylase**. This enzyme catalyzes the addition of a carboxyl group ($CO_2$) to specific **glutamic acid (Glu)** residues on the N-terminal end of clotting factors. This post-translational modification converts them into **gamma-carboxyglutamic acid (Gla)** residues. The addition of this second carboxyl group gives the proteins a strong negative charge, allowing them to bind **Calcium ($Ca^{2+}$) ions**. This calcium binding acts as a "bridge," enabling the clotting factors to anchor onto the negatively charged phospholipid membranes of activated platelets, which is a prerequisite for the coagulation cascade. **Analysis of Options:** * **A. Glycosylation:** This involves the addition of carbohydrates to proteins (e.g., in the Golgi apparatus) and is not mediated by Vitamin K. * **C. Acetylation:** This is the addition of an acetyl group (common in histone modification) and is unrelated to the activation of clotting factors. * **D. Phosphorylation:** This is the addition of a phosphate group by kinases, primarily used in signal transduction and enzyme regulation. **High-Yield Clinical Pearls for NEET-PG:** * **Vitamin K Dependent Factors:** Factors **II, VII, IX, X**, and Proteins **C and S**. * **Warfarin Mechanism:** It inhibits **Vitamin K Epoxide Reductase (VKOR)**, preventing the regeneration of active (reduced) Vitamin K, thereby inhibiting carboxylation. * **Lab Marker:** Prothrombin Time (PT) is the most sensitive marker for Vitamin K deficiency because Factor VII has the shortest half-life. * **Newborns:** They are born with sterile guts (no Vitamin K-producing bacteria) and low placental transfer, necessitating a prophylactic Vitamin K injection to prevent **Hemorrhagic Disease of the Newborn**.

Q: A 30-year-old chronically malnourished male presented with complaints of weakness, lassitude, anorexia, abdominal discomfort, diarrhea, apathy, lethargy, and mild disorientation. On examination, glossitis and dermatitis in sun-exposed areas were noted. All of the following enzymes use the above deficient vitamin as a coenzyme EXCEPT:

Transaminase. ### Explanation **Clinical Diagnosis: Pellagra (Vitamin B3 / Niacin Deficiency)** The patient presents with the classic "3 Ds" of Pellagra: **Dermatitis** (Casal’s necklace/sun-exposed areas), **Diarrhea**, and **Dementia** (lethargy, apathy, disorientation), along with glossitis. This indicates a deficiency of **Niacin (Vitamin B3)**, which serves as a precursor for the coenzymes **NAD+** and **NADP+**. **Why Transaminase is the Correct Answer:** Transaminases (e.g., ALT, AST) do not use Niacin. Instead, they require **Pyridoxal Phosphate (PLP)**, the active form of **Vitamin B6**, as a mandatory coenzyme for the transfer of amino groups. **Analysis of Incorrect Options (Enzymes that DO use Niacin):** * **Glyceraldehyde 3-phosphate dehydrogenase:** A key enzyme in glycolysis that requires **NAD+** as an electron acceptor to convert G3P to 1,3-bisphosphoglycerate. * **Beta-ketoacyl reductase:** A component of the Fatty Acid Synthase complex involved in lipogenesis; it requires **NADPH** as a reducing agent. * **Pyruvate dehydrogenase (PDH):** A multi-enzyme complex that converts pyruvate to Acetyl-CoA. It requires five cofactors: Thiamine (B1), Riboflavin (B2), **Niacin (B3 as NAD+)**, Pantothenic acid (B5), and Lipoic acid. **High-Yield Clinical Pearls for NEET-PG:** * **Precursor:** Niacin can be synthesized from the amino acid **Tryptophan** (60 mg Tryptophan = 1 mg Niacin). * **Hartnup Disease:** Defective transport of neutral amino acids (Tryptophan) leading to pellagra-like symptoms. * **Carcinoid Syndrome:** Increased tryptophan metabolism into serotonin leads to secondary niacin deficiency. * **Corn/Maize Diets:** Low in tryptophan and contains "niacytin" (bound niacin), often leading to Pellagra in endemic areas.

Q: What is the role of Vitamin K in the clotting cycle activation?

Reduction. To understand why **Reduction** is the correct answer, we must look at the Vitamin K cycle and the specific step required to *initiate* the activation of clotting factors. ### 1. Why Reduction is Correct Vitamin K exists in the body primarily in its inactive (oxidized) form, **Vitamin K Epoxide**. For it to act as a cofactor for the clotting cascade, it must first be converted into its active form, **Vitamin K Hydroquinone**. This conversion is a **reduction** process catalyzed by the enzyme **Vitamin K Epoxide Reductase (VKOR)**. Only the reduced form can facilitate the subsequent step of clotting factor activation. ### 2. Why Other Options are Incorrect * **Carboxylation:** While Vitamin K is essential for the **gamma-carboxylation** of glutamic acid residues on Factors II, VII, IX, and X, this is the *action* Vitamin K performs, not the process that *activates the Vitamin K cycle* itself. * **Hydroxylation:** This is a different biochemical modification (common in collagen synthesis via Vitamin C) and is not part of the Vitamin K-dependent clotting process. * **Oxidation:** This is the result of the clotting factor activation. When Vitamin K helps carboxylate a clotting factor, it becomes **oxidized** into an inactive epoxide. Therefore, oxidation terminates its activity rather than activating the cycle. ### 3. High-Yield Clinical Pearls for NEET-PG * **Mechanism of Warfarin:** Warfarin (Coumadin) acts by inhibiting **Vitamin K Epoxide Reductase**. By preventing the **reduction** of Vitamin K, it keeps the vitamin in its inactive oxidized state, thereby inhibiting the synthesis of functional Factors II, VII, IX, X, Protein C, and Protein S. * **Factors affected:** Remember the mnemonic "1972" (Factors 10, 9, 7, 2). * **Calcium Binding:** Gamma-carboxylation allows these factors to bind to **Calcium (Ca²⁺)**, which is essential for their attachment to phospholipid membranes during clot formation.

Q: Which of the following is common to both acyl carrier protein and coenzyme A?

Phosphopantotheine is the reactive group. **Explanation:** The correct answer is **C. Phosphopantotheine is the reactive group.** Both **Coenzyme A (CoA)** and **Acyl Carrier Protein (ACP)** are essential molecules in lipid metabolism. They share a common functional unit: **4'-phosphopantotheine**, which is derived from Vitamin B5 (Pantothenic acid). This prosthetic group contains a terminal **thiol (-SH) group** that forms a high-energy thioester bond with acyl groups, allowing them to act as carriers of fatty acid chains during synthesis and oxidation. **Analysis of Options:** * **A. Location:** CoA is found in both mitochondria (Beta-oxidation, TCA cycle) and cytoplasm. However, ACP is primarily a component of the **Fatty Acid Synthase (FAS) multienzyme complex**, which is located exclusively in the **cytosol** in humans. * **B. Carriers of folate:** This is incorrect. Folate (Vitamin B9) carriers are typically related to one-carbon metabolism (e.g., Tetrahydrofolate). CoA and ACP carry **acyl/acetyl groups**, not folate. * **D. Phosphorylated to tyrosine:** This is biologically irrelevant to these cofactors. Phosphopantotheine is linked to a **serine residue** in ACP, not tyrosine. **High-Yield NEET-PG Pearls:** * **Vitamin Link:** Pantothenic acid (B5) is the precursor for both CoA and ACP. * **Functional Difference:** CoA is a "soluble" carrier used in various pathways (TCA, Heme synthesis, Beta-oxidation), whereas ACP is a "fixed" carrier within the Fatty Acid Synthase complex for de novo lipogenesis. * **The "Business End":** The reactive part of both molecules is the **Sulfhydryl (-SH) group**, which is why CoA is often written as CoA-SH.

Q: What is the Recommended Dietary Allowance (RDA) of thiamine per 1000 kcal of energy per day?

0.5 mg. **Explanation:** **1. Why Option A is correct:** Thiamine (Vitamin B1) acts as a crucial coenzyme in the form of **Thiamine Pyrophosphate (TPP)** for key enzymes in carbohydrate metabolism, such as Pyruvate Dehydrogenase and α-ketoglutarate dehydrogenase. Because thiamine is essential for oxidative decarboxylation in energy production, its requirement is directly proportional to caloric intake. The established RDA for thiamine is **0.5 mg per 1000 kcal** of energy consumed. This ensures that the metabolic machinery has sufficient cofactors to process the glucose load. **2. Why other options are incorrect:** * **Options B, C, and D (0.6, 0.7, 0.8 mg):** These values exceed the standard recommended baseline for healthy adults. While requirements may increase slightly during physiological stress, pregnancy, or lactation (usually an additional 0.2–0.3 mg/day), the standard benchmark used in medical examinations for energy-linked calculation is strictly 0.5 mg/1000 kcal. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Enzymes requiring TPP:** Remember the mnemonic **ATP** (α-ketoglutarate dehydrogenase, Transketolase, and Pyruvate dehydrogenase). * **Diagnostic Marker:** The best method to assess thiamine status is measuring **Erythrocyte Transketolase activity**. * **Wernicke-Korsakoff Syndrome:** Classically seen in alcoholics. **Rule:** Always administer thiamine *before* glucose in a malnourished patient to prevent precipitating acute Wernicke encephalopathy. * **Deficiency:** Leads to **Beriberi**. * *Dry Beriberi:* Polyneuritis and muscle wasting. * *Wet Beriberi:* High-output heart failure and edema. * **Dietary Note:** Polishing rice removes the thiamine-rich aleurone layer, leading to deficiency in populations reliant on white rice.

Q: Which of the following reactions is affected in patients with scurvy?

Hydroxylation. **Explanation:** **Scurvy** is caused by a deficiency of **Vitamin C (Ascorbic Acid)**. Vitamin C acts as a vital co-factor for the enzymes **prolyl hydroxylase** and **lysyl hydroxylase**. These enzymes are responsible for the **hydroxylation** of proline and lysine residues in pre-procollagen. 1. **Why Hydroxylation is Correct:** Hydroxylation is essential for the cross-linking of collagen fibers, which provides structural integrity and tensile strength to connective tissues. In the absence of Vitamin C, the iron cofactor in these enzymes remains in the ferric ($Fe^{3+}$) state; Vitamin C reduces it back to the ferrous ($Fe^{2+}$) state, maintaining enzymatic activity. Without this, collagen remains unstable, leading to the fragile capillaries and poor wound healing seen in scurvy. 2. **Why Other Options are Incorrect:** * **Carboxylation:** This is primarily associated with **Vitamin K** (gamma-carboxylation of clotting factors) and **Biotin** (ABC enzymes: Acetyl-CoA, Propionyl-CoA, and Pyruvate carboxylase). * **Acetylation:** This involves **Coenzyme A** (derived from Vitamin B5/Pantothenic acid). * **Transamination:** This is the hallmark reaction of **Pyridoxal Phosphate (PLP)**, the active form of Vitamin B6. **Clinical Pearls for NEET-PG:** * **Classic Triad of Scurvy:** Gum bleeding, petechiae/ecchymosis, and perifollicular hemorrhages ("Corkscrew hairs"). * **Infantile Scurvy (Barlow’s Disease):** Presents with subperiosteal hemorrhage and "frog-leg" position. * **Radiological Signs:** Frankel’s line (dense provisional calcification) and Wimberger’s ring sign.

Question 1

Which drugs form complexes with pyridoxal?

Accepted Answer

Both Isoniazid and Penicillamine

Answer

Isoniazid

Answer

Penicillamine

Answer

Rifampicin

Question 2

An individual with megaloblastic anemia is found to have a significant folate deficiency. Erythropoiesis is hampered in this patient due to his inability to perform which type of enzymatic reaction?

Accepted Answer

Methylation

Answer

Acyl transfer

Answer

Carboxylation

Answer

Decarboxylation

Question 3

Which of the following statements about vitamin K are true?

Accepted Answer

Requires exposure to sunlight

Answer

Increases the synthesis of factor II, VII, IX and X

Answer

Causes hemolytic anemia in patients with G–6–PD deficiency

Answer

Half-life is less than 6 hours

Question 4

What is the biochemical role of vitamin K in the post-translational modification of clotting factors?

Accepted Answer

Carboxylation

Answer

Glycosylation

Answer

Acetylation

Answer

Phosphorylation

Question 5

A 30-year-old chronically malnourished male presented with complaints of weakness, lassitude, anorexia, abdominal discomfort, diarrhea, apathy, lethargy, and mild disorientation. On examination, glossitis and dermatitis in sun-exposed areas were noted. All of the following enzymes use the above deficient vitamin as a coenzyme EXCEPT:

Accepted Answer

Transaminase

Answer

Glyceraldehyde 3-phosphate dehydrogenase

Answer

Beta-ketoacyl reductase

Answer

Pyruvate dehydrogenase

Question 6

What is the role of Vitamin K in the clotting cycle activation?

Accepted Answer

Reduction

Answer

Carboxylation

Answer

Hydroxylation

Answer

Oxidation

Question 7

A 25-year-old alcoholic man presents with easy fatigability and moderate pallor for the past six months. His Hb is 5.2 g/dL. What is the most appropriate initial treatment?

Accepted Answer

Pyridoxine supplementation

Answer

Iron supplementation

Answer

Ascorbic acid supplementation

Answer

Vitamin B12 supplementation

Question 8

Which of the following is common to both acyl carrier protein and coenzyme A?

Accepted Answer

Phosphopantotheine is the reactive group

Answer

Located in mitochondria as well as cytoplasm

Answer

Carriers of folate

Answer

Phosphorylated to tyrosine

Question 9

What is the Recommended Dietary Allowance (RDA) of thiamine per 1000 kcal of energy per day?

Accepted Answer

0.5 mg

Answer

0.6 mg

Answer

0.7 mg

Answer

0.8 mg

Question 10

Which of the following reactions is affected in patients with scurvy?

Accepted Answer

Hydroxylation

Answer

Carboxylation

Answer

Acetylation

Answer

Transamination

Vitamins and Coenzymes — MCQs

Vitamins and Coenzymes — MCQs

On this page

Practice by Chapter

Want unlimited practice?